|
Volumn 2, Issue 6, 2000, Pages 438-443
|
P53 autoantibodies in 1006 patients followed up for breast cancer
|
Author keywords
Breast; Cancer; Monitoring; P53 autoantibodies
|
Indexed keywords
AUTOANTIBODY;
PROTEIN P53;
ANTIBODY SCREENING;
ARTICLE;
BLOOD SAMPLING;
BREAST CANCER;
CANCER DIAGNOSIS;
CELL ACTIVITY;
CONTROLLED STUDY;
CORRELATION FUNCTION;
DISEASE COURSE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FOLLOW UP;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MENOPAUSE;
PROGNOSIS;
TREATMENT OUTCOME;
TUMOR CELL;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AUTOANTIBODIES;
AUTOANTIGENS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
COHORT STUDIES;
DISEASE PROGRESSION;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MASTECTOMY;
MENOPAUSE;
MIDDLE AGED;
NEOPLASM PROTEINS;
TAMOXIFEN;
TREATMENT OUTCOME;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 0034469493
PISSN: 14655411
EISSN: None
Source Type: Journal
DOI: 10.1186/bcr91 Document Type: Article |
Times cited : (37)
|
References (17)
|